Irradiation of regional nodes in breast cancer patients affects overall survival
the ONA take:
Irradiation of regional nodes in patients with stage I-III breast cancer has a minimal effect on overall survival, according to a recent study published in The New England Journal of Medicine; however, irradiation improved disease-free survival, distant-disease-free survival, and breast cancer mortality.
For the phase III trial, researchers enrolled 4,004 patients with positive axillary lymph nodes, or centrally or medially located primary tumors with negative lymph nodes. Patients were randomly assigned to receive whole-breast or thoracic-wall irradiation plus regional nodal irradiation or whole-breast or thoracic-wall irradiation alone.
Results showed that regional irradiation benefits patients with early stage breast cancer and acute adverse events associated with regional irradiation were modest.
However, the authors note that these results do not apply to patients with laterally located node-negative cancers, which represent the largest patient subgroup of early-stage breast cancers in first-world countries. The investigators plan to continue monitoring patients for a median follow-up of 20 years.
Irradiation of regional nodes in patients with stage I-III breast cancer has a minimal effect on overall survival.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|